Publications

517 Publications Available
November 08, 2012
Future Oncology

Researchers evaluate blocking the MET pathway to prevent post-bevacizumab treatment tumor recurrence, providing a strong rationale for using a combination of MET and VEGF receptor inhibitors to treat glioblastoma patients.

October 01, 2012
Genome Research

Researchers have developed an integrated systems-biology approach to identifying novel cancer genes contributing to endometrial tumorigenesis. Their results revealed 12 potential driver cancer genes including 10 tumor-suppressor candidates and two oncogene candidates.

September 15, 2012
Cancer Research

Researchers created a mouse model of prostate cancer with inducuble PTEN disruption plus BRAF(V600E) expression.

August 17, 2012
Cell

A group of researchers, including a member of the CTD² network, has identified 56 candidate genes upon which cancer cells are uniquely dependent for survival.

August 15, 2012
Science Translational Medicine

The comprehensive characterization of a large number of cancer genomes will eventually lead to a compendium of genetic alterations in specific cancers.

August 10, 2012

Researchers describe emerging approaches that aim to determine which altered genes are actually contributing to cancer, as well as their potential as therapeutic targets.

July 19, 2012
Oncogene

Investigators screemed a library of kinases that lead to activation of the MAPK pathway and identified PAK1.

April 15, 2012
Genes and Development

Glioblastoma is both the most common and lethal primary malignant brain tumor.

Pages

CSV

.